(Bloomberg) — For all the recent backlash to drug price increases that have incited politicians' anger and roiled markets, a curious thing happened in the third quarter: Prices for generic drugs, which make up 85 percent of prescriptions, hardly increased at all.
That's according to an analysis from Bloomberg Intelligence analyst Jonathan Palmer, which shows inflation among generic drugs dropping from 4 percent two years ago to zero.
Prices of more expensive brand-name drugs have been increasing at more than 10 percent a year in that period.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
